Hi WD and @jcurve ,
With what FrankAZ found, I would be happy to see them back in an area that they know. Cannabis has turned out to be a mess, not only for CGB but for investors and the industry as a whole. If Australia does not move on this drug/driving legislation, it will, IMO, make life extremely difficult for the players that are left.
We will have to see what 2023 holds for the Cannabis industry here in Aus.
Let's see what they roll out tomorrow. It would be nice to have a little early Chrissie pressie considering how the market wrapped up for 2023.
- Forums
- ASX - By Stock
- CGB
- Court Update November 28th 2022 Medcan v CGB
Court Update November 28th 2022 Medcan v CGB, page-39
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online